Summary

Middle East Smart Healthcare Market Summary

The Middle East smart healthcare market sizewas estimated at USD 4.94 billion in 2024 and is projected to reach USD 15.43 billion by 2033, growing at a CAGR of 13.4% from 2025 to 2033. This growth is attributed to the technological advancements, rising healthcare costs, and the increasing demand for efficient, patient-centric care delivery.

The industry is witnessing strong adoption of RFID-based solutions, such as Kanban systems and smart cabinets, which help hospitals optimize inventory control, reduce wastage, and improve supply chain efficiency. For instance, in August 2022, Sharjah Public Library began implementing an advanced RFID library system developed by 3M, with Arabian Advanced Systems (AAS) managing installation, staff training, and support, aiming to enhance collection management efficiency and automate processes such as circulation and inventory control in one of the largest RFID library deployments in the Middle East.

Rapid adoption of virtual healthcare ecosystems that leverage advanced technologies significantly drives the market growth. In December 2024, UAE's Mulk International and India’s Ajeenkya DY Patil Group launched the region’s first large-scale global virtual hospital with a USD 27.2 million (AED 100 million) investment. Featuring over 20,000 doctors, 24/7 telehealth consultations, discounted medicines, smart ambulances, mobile clinics, and AI-driven ICU pods, this initiative highlights how large-scale digital health investments are reshaping patient care models. Such projects not only address gaps in healthcare accessibility but also accelerate the integration of AI, IoT, and telemedicine into mainstream healthcare, fueling the growth of the Middle East smart healthcare market.

Furthermore, countries such as the UAE are actively embracing advanced technologies to transform their healthcare sector through the development of Smart Hospitals. Despite this progress, the country still depends heavily on imported high-end medical equipment. To address this gap, the UAE has established strategic partnerships with leading U.S. medical device companies such as GE Healthcare, Philips Healthcare, Abbott, 3M, and Medtronic. These collaborations align with the government’s broader vision of achieving self-sufficiency in pharmaceuticals and medical devices.

The nation’s pro-business policies and forward-looking initiatives continue to attract global pharmaceutical leaders to expand their presence in the region. A notable example of this innovation-driven approach is the Dubai 3D Printing Strategy, which aims to revolutionize healthcare manufacturing. In line with this vision, the Dubai Health Authority recently partnered with Sinterex, a medical 3D printing startup, to establish dedicated 3D printing laboratories. These labs are being set up at Rashid, Latifa, Dubai, and Hatta Hospitals, enabling point-of-care production of customized medical devices and enhancing treatment capabilities.

The Middle East is rapidly positioning itself as a center for digital health innovation, with governments and private sector players investing heavily in AI, telemedicine, and smart infrastructure. Growing demand for advanced care delivery models and the region’s efforts to become a global leader in healthcare innovation are driving large-scale collaborations and technology deployments. AI integration is emerging as a transformative force in the Middle East's smart healthcare market, fostering advancements in diagnostics, precision medicine, and next-generation care delivery.

In July 2025, the US-UAE healthcare partnership entered a new phase with the launch of the 1GW Stargate UAE AI supercomputing cluster, aimed at accelerating genomics research, drug discovery, and AI-driven healthcare solutions. Complementing progress in telemedicine and smart hospital technologies, this collaboration shows how the region is leveraging global partnerships, supercomputing power, and AI innovation to enhance healthcare infrastructure and deliver life-changing medical advancements beyond national borders.

Middle East Smart Healthcare Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East smart healthcare market report based on product, end-use, and country

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• RFID Kanban Systems
• RFID Smart Cabinets
• Electronic Health Records (EHR)
o Web-based EHR
o Client-server Based EHR
• Telemedicine
o Hardware
o Software
o Others
• mHealth
o Monitoring Services
o Diagnosis Services
o Healthcare Systems Strengthening
o Others
• Smart Pills
• Smart Syringes
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Home Care Settings
• Others
• Country Outlook (Revenue, USD Million, 2021 - 2033)
• Saudi Arabia
• UAE
• Kuwait
• Qatar
• Oman

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product Type
1.2.2. End use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. List of Abbreviations
1.11. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising adoption of mHealth
3.2.1.2. Supportive government programs
3.2.1.3. Technological advancements in medical devices
3.2.1.4. Integration of AI and big data analytics
3.2.1.5. Emphasis on data-driven healthcare and electronic health records (EHRs)
3.2.2. Market Restraint Analysis
3.2.2.1. High initial investment and infrastructure costs
3.2.2.2. Data privacy and security concerns
3.2.3. Industry Opportunity Analysis
3.2.4. Industry Challenge Analysis
3.2.5. Case Studies
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
Chapter 4. Middle East Smart Healthcare Market: Product Type Estimates & Trend Analysis
4.1. Product Type Segment Dashboard
4.2. Product Type Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
4.4. RFID Kanban Systems
4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. RFID Smart Cabinets
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Electronic Health Records (EHR)
4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.2. Web-based HER
4.6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6.3. Client-server Based EHR
4.6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Telemedicine
4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7.2. Hardware
4.7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7.3. Software
4.7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7.4. Others
4.7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. mHealth
4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.2. Monitoring Services
4.8.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.3. Diagnosis Services
4.8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.4. Healthcare Systems Strengthening
4.8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8.5. Others
4.8.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.9. Smart Pills
4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.10. Smart Syringes
4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East Smart Healthcare Market: End Use Estimates & Trend Analysis
5.1. End Use Segment Dashboard
5.2. End Use Market Share Movement Analysis, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
5.4. Hospitals
5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Home Care Settings
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East Smart Healthcare Market: Country Estimates & Trend Analysis
6.1. Country Market Dashboard
6.2. Country Market: Key Takeaways
6.2.1. Saudi Arabia
6.2.1.1. Key country dynamic
6.2.1.2. Regulatory framework
6.2.1.3. Competitive insights
6.2.1.4. Saudi Arabia smart healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
6.2.2. UAE
6.2.2.1. Key country dynamic
6.2.2.2. Regulatory framework
6.2.2.3. Competitive insights
6.2.2.4. UAE smart healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
6.2.3. Kuwait
6.2.3.1. Key country dynamic
6.2.3.2. Regulatory framework
6.2.3.3. Competitive insights
6.2.3.4. Kuwait smart healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
6.2.4. Qatar
6.2.4.1. Key country dynamic
6.2.4.2. Regulatory framework
6.2.4.3. Competitive insights
6.2.4.4. Qatar smart healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
6.2.5. Oman
6.2.5.1. Key country dynamic
6.2.5.2. Regulatory framework
6.2.5.3. Competitive insights
6.2.5.4. Oman smart healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Oracle
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. GE Healthcare
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. Siemens Healthineers
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Medtronic
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. McKesson Corporation
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Samsung
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Apple Inc.
7.5.7.1. Overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Cisco
7.5.8.1. Overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives
7.5.9. IBM
7.5.9.1. Overview
7.5.9.2. Financial performance
7.5.9.3. Product benchmarking
7.5.9.4. Strategic initiatives
7.5.10. AT&T Inc.
7.5.10.1. Overview
7.5.10.2. Financial performance
7.5.10.3. Product benchmarking
7.5.10.4. Strategic initiatives
7.5.11. Veradigm LLC (Allscripts)
7.5.11.1. Overview
7.5.11.2. Financial performance
7.5.11.3. Product benchmarking
7.5.11.4. Strategic initiatives
7.5.12. Pepperl+Fuchs Pvt. Ltd.
7.5.12.1. Overview
7.5.12.2. Financial performance
7.5.12.3. Product benchmarking
7.5.12.4. Strategic initiatives
7.5.13. Logi-Tag
7.5.13.1. Overview
7.5.13.2. Financial performance
7.5.13.3. Product benchmarking
7.5.13.4. Strategic initiatives